Literature DB >> 21671167

Lack of association of common polymorphism of LRP1 gene with myocardial infarction in a Chinese Han population.

Honggang Ren1, Tao Guo1, Huafang Wang1, Chunyan Sun1, Xiaoping Zhang1, Heng Mei1, Yu Hu2.   

Abstract

This study examined the association of a common polymorphic allele (25G) of the low-density lipoprotein receptor-related protein1 (LRP1) gene with myocardial infarction (MI). The genotypes of LRP1 25CG (rs35282763) were determined in 347 MI patients and 347 age- and sex-frequency-matched controls from an unrelated Chinese Han population. Factor VIII (FVIII) levels were measured in the MI patients and controls by chromogenic assay and enzyme-linked immunosorbent assay (ELISA). The results showed that LRP1 25CG (rs35282763) genotype distribution did not differ significantly between patients (n=206 for 25CC, n=122 for 25CG) and controls (n=191 for 25CC, n=126 for 25CG; P>0.05). The 25G allele was not associated with a reduced risk of MI (P>0.05). Further stratifications for age, sex, and other cardiovascular risk factors did not affect the negative findings. It was concluded that the presence of the G allele at the 25CG (rs35282763) polymorphism of the LRP1 is not associated with a reduced risk of MI, and genotyping for LRP1 25CG (rs35282763) polymorphism is not useful in assessing the individual risk of MI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671167     DOI: 10.1007/s11596-011-0370-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

Review 1.  Elevated factor VIII levels and the risk of thrombosis.

Authors:  P W Kamphuisen; J C Eikenboom; R M Bertina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-05       Impact factor: 8.311

2.  High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.

Authors:  J O'Donnell; E G Tuddenham; R Manning; G Kemball-Cook; D Johnson; M Laffan
Journal:  Thromb Haemost       Date:  1997-05       Impact factor: 5.249

3.  The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study.

Authors:  R P Tracy; A M Arnold; W Ettinger; L Fried; E Meilahn; P Savage
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

4.  Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosis.

Authors:  Nicholas Cunningham; Michael A Laffan; Richard A Manning; James S O'Donnell
Journal:  Blood Coagul Fibrinolysis       Date:  2005-10       Impact factor: 1.276

5.  Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.

Authors:  A Rumley; G D Lowe; P M Sweetnam; J W Yarnell; R P Ford
Journal:  Br J Haematol       Date:  1999-04       Impact factor: 6.998

6.  Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women.

Authors:  Giovanna Marchetti; Barbara Lunghi; Cristina Legnani; Michela Cini; Mirko Pinotti; Francesco Mascoli; Francesco Bernard
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

7.  Age- and gender-specific prevalence of cardiovascular risk factors in 40,102 patients with first-ever ischemic stroke: a Nationwide Danish Study.

Authors:  Klaus Kaae Andersen; Zorana Jovanovic Andersen; Tom Skyhøj Olsen
Journal:  Stroke       Date:  2010-10-21       Impact factor: 7.914

8.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; K K Wu; W D Rosamond; A R Sharrett; L E Chambless
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

9.  The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII.

Authors:  Natalya M Ananyeva; Yevgen M Makogonenko; Diana V Kouiavskaia; Jose Ruiz; Vincent Limburg; Alexander B Meijer; Alexey V Khrenov; Midori Shima; Dudley K Strickland; Evgueni L Saenko
Journal:  Blood Coagul Fibrinolysis       Date:  2008-03       Impact factor: 1.276

Review 10.  Levels of coagulation factors and venous thromboembolism.

Authors:  Armando Tripodi
Journal:  Haematologica       Date:  2003-06       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.